Fullerton Fund Management’s Boston Scientific BSX Stock Holding History

Fullerton Fund Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,195	Closed	-$200K	–	125
2026 Q1	$200K	Sell	3,195 -594,979	-99%	-$47.6M	0.02%	116
2025 Q4	$57M	Buy	598,174 +387,761	+184%	+$38M	2.49%	15
2025 Q3	$20.5M	Sell	210,413 -495,626	-70%	-$51.3M	0.79%	28
2025 Q2	$75.8M	Buy	706,039 +27,188	+4%	+$2.75M	3.07%	10
2025 Q1	$68.5M	Sell	678,851 -874,305	-56%	-$88M	4.4%	5
2024 Q4	$139M	Buy	1,553,156 +533,346	+52%	+$47M	4.85%	8
2024 Q3	$85.5M	Buy	1,019,810 +812,742	+393%	+$64.1M	3.59%	8
2024 Q2	$15.9M	Buy	207,068 +7,159	+4%	+$524K	0.72%	32
2024 Q1	$13.7M	Buy	+199,909	New	+$12.9M	0.65%	34
2023 Q3	–	Sell	-27,817	Closed	-$1.5M	–	59
2023 Q2	$1.5M	Buy	+27,817	New	+$1.45M	0.11%	55

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fullerton Fund Management's BSX Position: Q2 2026 in Review

Fullerton Fund Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,195 shares — an estimated $200K sold.

Fullerton Fund Management first reported a position in BSX in Q2 2023 and held it in 10 quarters. The position peaked at $139M in Q4 2024. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Fullerton Fund Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Fullerton Fund Management sold 3,195 Boston Scientific shares in Q2 2026, an estimated $200K.
Fullerton Fund Management first reported a position in Boston Scientific in Q2 2023 and held it in 10 quarters.
Fullerton Fund Management's Boston Scientific position peaked at $139M in Q4 2024.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Fullerton Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.